<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="11" ids="26333">Prostaglandins</z:chebi> are potent modulators of insulin sensitivity </plain></SENT>
<SENT sid="1" pm="."><plain>We systemically evaluated the association of 61 tag single-nucleotide polymorphisms (SNP) in 14 genes involved in <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> metabolism with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Among <z:hpo ids='HP_0000001'>all</z:hpo> genotyped SNPs, rs10483032 in the CBR3 (<z:chebi fb="1" ids="23019">carbonyl</z:chebi> reductase 3) gene, which encodes for an enzyme converting <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E(2) to <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> F2(α), was associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in 760 type 2 diabetic cases and 760 controls (stage-1 study) (P = 2.0 × 10(-4)) </plain></SENT>
<SENT sid="3" pm="."><plain>The association was validated in 1,615 cases and 1,162 controls (stage-2 study) (P = 0.009) </plain></SENT>
<SENT sid="4" pm="."><plain>The A allele at rs10483032 was associated with increased risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (odds ratio = 1.29; 95% confidence interval = 1.14-1.47; combined P &lt; 0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>The association was externally validated in the Finland-United States Investigation of <z:mp ids='MP_0002057'>NIDDM</z:mp> Genetics (FUSION) study (P = 3.7 × 10(-4)) </plain></SENT>
<SENT sid="6" pm="."><plain>The risk A allele was associated with higher homeostasis model assessment of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (HOMA-IR) in 1,012 non-diabetic controls and 1,138 non-diabetic subjects from the Stanford Asia-Pacific Program for <z:hpo ids='HP_0000822'>Hypertension</z:hpo> and <z:hpo ids='HP_0000855'>Insulin Resistance</z:hpo> (SAPPHIRe) family study </plain></SENT>
<SENT sid="7" pm="."><plain>CBR3 gene expression in human abdominal adipose tissue was negatively associated with fasting insulin and HOMA-IR </plain></SENT>
<SENT sid="8" pm="."><plain>CBR3 gene expression increased during differentiation of 3T3-L1 preadipocytes into adipocytes </plain></SENT>
<SENT sid="9" pm="."><plain>Knockdown of CBR3 in 3T3-L1 preadipocytes enhanced adipogenesis and peroxisome proliferator-activator receptor-γ response element reporter activity </plain></SENT>
<SENT sid="10" pm="."><plain>Our results indicated that genetic polymorphism in the CBR3 gene conferred risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in Chinese </plain></SENT>
<SENT sid="11" pm="."><plain>The association was probably mediated through modulation of adipogenesis </plain></SENT>
</text></document>